Break it Down: One step closer to treating ALS

Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds.

In this episode, Tylah Tully gives the skinny on Neurizon Therapeutics (ASX:NUZ) HEALEY ALS Platform Trial, as the company makes progress developing its lead asset NUZ-001.

Tune in to get the latest.